Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

Molecular Mechanisms and Clinical Impact of Acquired and Intrinsic Fosfomycin Resistance.

Castañeda-García A, Blázquez J, Rodríguez-Rojas A.

Antibiotics (Basel). 2013 Apr 16;2(2):217-36. doi: 10.3390/antibiotics2020217. Review.

2.

Role of Old Antibiotics in the Era of Antibiotic Resistance. Highlighted Nitrofurantoin for the Treatment of Lower Urinary Tract Infections.

Munoz-Davila MJ.

Antibiotics (Basel). 2014 Feb 10;3(1):39-48. doi: 10.3390/antibiotics3010039. Review.

3.

Resistance to fosfomycin: Mechanisms, Frequency and Clinical Consequences.

Falagas ME, Athanasaki F, Voulgaris GL, Triarides NA, Vardakas KZ.

Int J Antimicrob Agents. 2018 Sep 27. pii: S0924-8579(18)30272-3. doi: 10.1016/j.ijantimicag.2018.09.013. [Epub ahead of print] Review.

PMID:
30268576
4.

[Fosfomycin--its significance for treatment of diseases due to multidrug-resistant bacteria].

Stock I.

Med Monatsschr Pharm. 2015 Jan;38(1):4-11. Review. German.

PMID:
26349119
5.

The revival of fosfomycin.

Michalopoulos AS, Livaditis IG, Gougoutas V.

Int J Infect Dis. 2011 Nov;15(11):e732-9. doi: 10.1016/j.ijid.2011.07.007. Epub 2011 Sep 25. Review.

6.
7.

Fosfomycin for the treatment of resistant gram-negative bacterial infections. Insights from the Society of Infectious Diseases Pharmacists.

Reffert JL, Smith WJ.

Pharmacotherapy. 2014 Aug;34(8):845-57. doi: 10.1002/phar.1434. Epub 2014 Apr 30. Review.

PMID:
24782335
8.

[Fosfomycin: past, present and future].

Baylan O.

Mikrobiyol Bul. 2010 Apr;44(2):311-21. Review. Turkish.

PMID:
20549968
10.

Fosfomycin: Pharmacological, Clinical and Future Perspectives.

Dijkmans AC, Zacarías NVO, Burggraaf J, Mouton JW, Wilms EB, van Nieuwkoop C, Touw DJ, Stevens J, Kamerling IMC.

Antibiotics (Basel). 2017 Oct 31;6(4). pii: E24. doi: 10.3390/antibiotics6040024. Review.

12.

Prevalence of Fosfomycin Resistance and Mutations in murA, glpT, and uhpT in Methicillin-Resistant Staphylococcus aureus Strains Isolated from Blood and Cerebrospinal Fluid Samples.

Fu Z, Ma Y, Chen C, Guo Y, Hu F, Liu Y, Xu X, Wang M.

Front Microbiol. 2016 Jan 11;6:1544. doi: 10.3389/fmicb.2015.01544. eCollection 2015.

13.

Cell-wall-inhibiting antibiotic combinations with activity against multidrug-resistant Klebsiella pneumoniae and Escherichia coli.

Hickman RA, Hughes D, Cars T, Malmberg C, Cars O.

Clin Microbiol Infect. 2014 Apr;20(4):O267-73. doi: 10.1111/1469-0691.12374. Epub 2013 Oct 2.

14.

CTX-M-15-producing urinary Escherichia coli O25b-ST131-phylogroup B2 has acquired resistance to fosfomycin.

Oteo J, Orden B, Bautista V, Cuevas O, Arroyo M, Martínez-Ruiz R, Pérez-Vázquez M, Alcaraz M, García-Cobos S, Campos J.

J Antimicrob Chemother. 2009 Oct;64(4):712-7. doi: 10.1093/jac/dkp288. Epub 2009 Aug 11.

PMID:
19671590
15.

Fosfomycin: use beyond urinary tract and gastrointestinal infections.

Falagas ME, Giannopoulou KP, Kokolakis GN, Rafailidis PI.

Clin Infect Dis. 2008 Apr 1;46(7):1069-77. doi: 10.1086/527442. Review.

PMID:
18444827
16.

Antimicrobial Susceptibility and Molecular Mechanisms of Fosfomycin Resistance in Clinical Escherichia coli Isolates in Mainland China.

Li Y, Zheng B, Li Y, Zhu S, Xue F, Liu J.

PLoS One. 2015 Aug 7;10(8):e0135269. doi: 10.1371/journal.pone.0135269. eCollection 2015.

17.

Fosfomycin: an old--new antibiotic.

Raz R.

Clin Microbiol Infect. 2012 Jan;18(1):4-7. doi: 10.1111/j.1469-0691.2011.03636.x. Epub 2011 Sep 13. Review.

18.
19.

Fosfomycin for the treatment of infections caused by multidrug-resistant non-fermenting Gram-negative bacilli: a systematic review of microbiological, animal and clinical studies.

Falagas ME, Kastoris AC, Karageorgopoulos DE, Rafailidis PI.

Int J Antimicrob Agents. 2009 Aug;34(2):111-20. doi: 10.1016/j.ijantimicag.2009.03.009. Epub 2009 Apr 28. Review.

PMID:
19403273
20.

Fosfomycin: evaluation of the published evidence on the emergence of antimicrobial resistance in Gram-negative pathogens.

Karageorgopoulos DE, Wang R, Yu XH, Falagas ME.

J Antimicrob Chemother. 2012 Feb;67(2):255-68. doi: 10.1093/jac/dkr466. Epub 2011 Nov 16. Review.

PMID:
22096042

Supplemental Content

Support Center